Cardiovascular complications in COVID-19

The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. COVID-19 is associated with a number of cardiovascular complications, including myocardial injury and myocarditis, AMI, heart failure, dysrhythmias, and VTE. Some of the medications utilized to treat COVID-19 also have potential cardiac complications. It is important for the emergency clinicians to be aware of these complications when treating the COVID-19 patient. To read more-https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165109/

7 Likes

LikeAnswersShare
Nicely complied and comprehensive educative post. Drugs used in heart ailments should be used in covid after due evaluation and proper investigation ,pros and cons should be weigh throughly before it is used in COVID Infection.
Thanks Dr Dinesh Gupta
0
NICE. UPDATE AND USEFUL..
Informative

Cases that would interest you